United States

The high cost of drugs is the price we pay for innovation

A veterinarian prepares a dosage of rabies vaccine at the 2014 Taipei Pet Show at Nangang Exhibition Hall in Taipei July 11, 2014. The show runs from July 11 to 14. REUTERS/Pichi Chuang (TAIWAN - Tags: SOCIETY DRUGS) - RTR3Y3TS

The relationship between unmet medical need, innovation, and high drug prices is complex and politically fraught. Image: REUTERS/Pichi Chuang

Ross Breckenridge
Chief Executive, Silver Creek Pharmaceuticals
Share:
Our Impact
The Big Picture
Explore and monitor how United States is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

United States

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
United StatesGlobal HealthEmerging Technologies
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

These 3 electricity regimes give us a glimpse of our global energy future

Lamé Verre, Sharif Al Olama and Ayla Majid

November 30, 2023

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum